Literature DB >> 19522092

Strategic Advisory Group of Experts: recommendations on the use of licensed human H5N1 influenza vaccines in the interpandemic period.

.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19522092

Source DB:  PubMed          Journal:  Wkly Epidemiol Rec        ISSN： 0049-8114


× No keyword cloud information.
  4 in total

1.  Telephone monitoring of adverse events during an MF59®-adjuvanted H5N1 influenza vaccination campaign in Taiwan.

Authors:  Wan-Ting Huang; Chih-Hsi Chang; Mei-Chen Peng
Journal:  Hum Vaccin Immunother       Date:  2013-10-08       Impact factor: 3.452

2.  "Prepandemic" immunization for novel influenza viruses, "swine flu" vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events.

Authors:  David Evans; Simon Cauchemez; Frederick G Hayden
Journal:  J Infect Dis       Date:  2009-08-01       Impact factor: 5.226

3.  The safety and immunogenicity of a MF59-adjuvanted H5N1 prepandemic influenza vaccine in healthy adults primed with homologous or heterologous H5N1 vaccines: an observational study.

Authors:  Sung-Hsi Wei; Ming-Tsan Liu; Yao-Chou Tsai; Chung-Hsin Liao; Chih-Ming Chen; Wei-Yao Wang; Yi-Lung Huang; Feng-Yee Chang; Pesus Chou
Journal:  BMC Infect Dis       Date:  2014-11-14       Impact factor: 3.090

4.  Influenza A(H5N1) vaccines: are we better prepared for the next pandemic?

Authors:  Wendy A Keitel; Pedro A Piedra
Journal:  J Infect Dis       Date:  2013-10-24       Impact factor: 5.226
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.